Chembio Diagnostics Inc
Change company Symbol lookup
Select an option...
CEMI Chembio Diagnostics Inc
MOJO MOJO Organics Inc
JSDA Jones Soda Co
NOBL ProShares S&P 500 Dividend Aristocrats ETF
NLY Annaly Capital Management Inc
NGG National Grid PLC
NEM Newmont Corporation
NDP Tortoise Energy Independence Fund, Inc
NCV AllianzGI Convertible & Income Fund
NCV AllianzGI Convertible & Income Fund

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The HIV 1/2 rapid tests employ in-licensed and lateral flow technologies that are used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format and a barrel format. Its HIV 1/2 rapid antibody detection test incorporates the Dual Path Platform (DPP) POCT technology. The DPP HIV 1/2 Assay detects antibodies to HIV 1 and 2 in oral fluid samples, as well as in all blood matrices. The Company's product pipeline includes a multiplex rapid test for earlier detection of HIV and a multiplex test that detects HIV and Syphilis specific antibodies.

Closing Price
Day's Change
2.04 (39.84%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Amazon's stock rallies for 3rd straight day, retraces nearly half what it lost amid COVID-19 crisis

1:07 pm ET March 19, 2020 (MarketWatch)

Shares of Inc. (AMZN) rallied 4.8% in afternoon trading Thursday, and have now retraced nearly half what they lost as a result of the COVID-19 health crisis. The stock closed at a record $2,170.22 on Feb. 19, then fell $493.61, or 22.7%, to a one-year closing low of $1,676.61 on March 16. After rising $241.14, or 14.4%, amid a three-day win streak since that closing low, the e-commerce giant's stock has retraced 48.9% of the COVID-19 decline. As more retail stores announce closures (, Amazon has said that it was experiencing high demand for coronavirus-related items (, including disinfecting wipes, hand sanitizer and paper towels. Among shares of the other largest market-capitalization companies, Microsoft Corp. (MSFT) has retraced 21.4% of its COVID-19 selloff, Apple Inc. (AAPL) has retraced 6.8% and Google-parent Alphabet Inc. (GOOGL) has retraced 11.5%. Meanwhile, the Dow Jones Industrial Average has retraced just 2.0%, as it closed at a fresh low on Wednesday, while the Nasdaq Composite has retraced 9.6%.

-Tomi Kilgore; 415-439-6400;

(END) Dow Jones Newswires

March 19, 2020 13:07 ET (17:07 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.